Michael Shehata

Dr. Michael Shehata is a board-certified Cardiac Electrophysiologist for the Smidt Heart Institute at Cedars-Sinai Medical Center. He is the Division Chief of Cardiac Electrophysiology and Director for the Interventional Electrophysiology Laboratory and the Clinical Cardiology Electrophysiology Fellowship Program. Dr. Shehata specializes in catheter ablation for complex atrial and ventricular arrhythmias, cardiac electronic implanted devices such as pacemakers and defibrillators, conduction system pacing, and left atrial appendage occlusion. He has an active research program and has acted as the principal investigator (PI) on multiple groundbreaking trials in novel ablation therapies for atrial fibrillation using pulsed field ablation, as well as leading the MICRA clinical trial and AVEIR DR trial at Cedars implanting novel completely leadless pacemakers in humans. He is currently also working on the use of unique mapping technologies in human atrial fibrillation that use machine learning to predict key drivers of atrial fibrillation unique to the individual patient with the goal of improving outcomes in treating this challenging arrhythmia. Dr. Shehata received his undergraduate degree at University of California Los Angeles in Chemical Engineering and earned his medical degree at University of California San Diego School of Medicine. He trained in cardiology and cardiac electrophysiology at Cedars-Sinai and then went on to UCLA as a junior faculty member in the Cardiac Arrhythmia Center.